Tirzepatide works on multiple fronts to support sustained weight reduction: Patients using tirzepatide under medical supervision have seen an average weight loss of 15% to 22% of their total body weight over the course of treatment, depending on dosage and duration
, '
Hammoud, R., & Drucker, D
In fact, clinical trial data shows improvements in psychological wellbeing in people taking tirzepatide
Furthermore, it has been reported elsewhere that the side effects of semaglutide 2.4 mg are mainly nausea, diarrhea, and cholelithiasis, which are typical for this drug class
reported in approximately 4060% of participants in higher-dose groups Vomiting reported in approximately 2030% of participants at higher doses Diarrhoea Constipation Decreased appetite (which, whilst contributing to weight loss, can also be uncomfortable) The majority of gastrointestinal events were mild to moderate in severity and tended to diminish over time as participants adjusted to the medication